UNI-PHARMA has announced plans to establish a new Research and Innovation Centre focused on the development of biopharmaceuticals, monoclonal antibodies, and other advanced therapeutics. The investment will strengthen the company's R&D capabilities, support the development of biosimilars and novel drug formulations, and expand its presence in new therapeutic areas.